Altavera Kit
Product Images NDC 70700-116

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Altavera (NDC 70700-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Alta-box (Alta Box)

ALTAVERA kit containing Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.15 mg and 0.03 mg. The packaging shows a 28 day regimen with 3 units of 3 tablet dispensers (28 tablets each). Labeled for prescription use only by Xiromed, LLC. The box is predominantly purple and white with branding and regulatory information visible.*

FDA Label Image

Altavera-label (Altavera Label)

ALTAVERA kit for oral use containing Levonorgestrel and Ethinyl Estradiol tablets, USP with strengths of 0.15 mg and 0.03 mg, respectively. The blister card shows a 28-day cycle arranged in four rows labeled Week 1 through Week 4, with seven circular tablet compartments per row representing days Sunday through Saturday. The tablets in Week 4 are shaded differently, indicating inactive or placebo tablets. The product is labeled by Xiromed, LLC.*

FDA Label Image

Chart

An illustration depicting comparative pregnancy rates per 100 women in one year with various contraceptive methods. It ranks methods from fewer pregnancies, such as implants, injections, intrauterine devices, and sterilization, to methods associated with more pregnancies, including no birth control, withdrawal, and spermicide. Birth control pills are grouped with skin patch and vaginal ring as moderately effective options.*

FDA Label Image

Ethinyl-e-altavera (Ethinyl E Altavera)

Chemical structure of Ethinyl Estradiol, an active ingredient in the drug product ALTAVERA (Levonorgestrel and Ethinyl Estradiol). The diagram shows molecular rings, hydroxyl groups, and a triple bond characteristic of its steroid framework.*

FDA Label Image

Fig 2

A forest plot chart displaying effect estimates (Odds Ratios or Relative Risks) with 95% confidence intervals from various women's contraceptive studies between 2002 and 2017, comparing 'Ever use' and 'Current use' of contraception. The x-axis represents effect estimates ranging from -1.5 to 2.0, with a reference line at 1.*

FDA Label Image

Figure1-alta (Figure1 Alta)

A horizontal bar chart comparing the number of women experiencing blood clots per 10,000 women years across four categories: Non-Pregnant Non-COC users (1 to 5), COC users (3 to 9), Pregnancy (5 to 20), and Postpartum (12 weeks only) with the highest range from 40 to 65. Additional note clarifies pregnancy data is based on actual pregnancy duration and model assumptions.*

FDA Label Image

Levo-altavera (Levo Altavera)

Chemical structure diagram of Levonorgestrel, showing the molecular arrangement with labeled carbon, hydrogen, oxygen atoms, hydroxyl group, and double bonds as part of its steroid framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.